Medicare Enrolled

Dr. Elena Lumezanu, MD

Rheumatology · Sewell, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
123 EGG HARBOR RD, Sewell, NJ 08080
8563020500
Registered in NPPES since 2008
NPI: 1275700858 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lumezanu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lumezanu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lumezanu

Dr. Elena Lumezanu is a rheumatology specialist in Sewell, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lumezanu performed 16,517 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Lumezanu received a total of $36 from 2 pharmaceutical and/or device companies across 3 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lumezanu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 36% volume in NJ $36 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
16,517
Medicare services
Top 36% in NJ for rheumatology
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 12,900 $18 $39
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
601 $100 $232
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
559 $8 $33
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
444 $10 $126
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
369 $12 $88
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
351 $4 $43
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
267 $8 $62
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
211 $68 $173
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
190 $7 $95
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
164 $57 $415
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
149 $145 $358
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
73 $121 $367
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
61 $23 $239
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
54 $12 $140
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
50 $101 $697
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
37 $1 $3
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
15 $15 $102
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
11 $16 $160
New patient office visit, complex (60-74 min) 11 $193 $466
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
82.4% medium
16.3% routine

Industry Payment Transparency

Open Payments through 2021 ↗
$36
Total received (2018-2021)
Avg $12/year across 3 years
Bottom 4% in NJ for rheumatology
2
Companies
3
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$12
2019
$13
2018
$11

Payments by company (2021)

Amgen Inc.
$12
Top 3 companies account for 100.0% of 2021 payments
All-time payments by company (2018-2021) ›
Amgen Inc.
$25
Genentech USA, Inc.
$11
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
Actemra · Enbrel
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Sewell?
Compare rheumatologists in the Sewell area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
134
County median income
$102,807
Nearest hospital to ZIP centroid (approximate)
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2021
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lumezanu is a mixed practice specialist, with moderate Medicare volume, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lumezanu experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lumezanu performed 12,900 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lumezanu receive payments from pharmaceutical companies?
Yes. Dr. Lumezanu received a total of $36 from 2 companies across 3 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lumezanu's costs compare to other rheumatologists in Sewell?
Dr. Lumezanu's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lumezanu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →